| Literature DB >> 36004979 |
Tutku Beduk1, Duygu Beduk2, Mohd Rahil Hasan3, Emine Guler Celik4, Jurgen Kosel1, Jagriti Narang3, Khaled Nabil Salama5, Suna Timur2,6.
Abstract
Many emerging technologies have the potential to improve health care by providing more personalized approaches or early diagnostic methods. In this review, we cover smartphone-based multiplexed sensors as affordable and portable sensing platforms for point-of-care devices. Multiplexing has been gaining attention recently for clinical diagnosis considering certain diseases require analysis of complex biological networks instead of single-marker analysis. Smartphones offer tremendous possibilities for on-site detection analysis due to their portability, high accessibility, fast sample processing, and robust imaging capabilities. Straightforward digital analysis and convenient user interfaces support networked health care systems and individualized health monitoring. Detailed biomarker profiling provides fast and accurate analysis for disease diagnosis for limited sample volume collection. Here, multiplexed smartphone-based assays with optical and electrochemical components are covered. Possible wireless or wired communication actuators and portable and wearable sensing integration for various sensing applications are discussed. The crucial features and the weaknesses of these devices are critically evaluated.Entities:
Keywords: biomarkers; biosensors; clinical diagnosis; electrochemical sensor; multiplexed detection; point-of-care (PoC) testing; smartphone-based detection
Mesh:
Substances:
Year: 2022 PMID: 36004979 PMCID: PMC9406027 DOI: 10.3390/bios12080583
Source DB: PubMed Journal: Biosensors (Basel) ISSN: 2079-6374
Figure 1Overview of smartphone-based biosensors for health monitoring.
Figure 2Working principle of electrochemical (A) and optical (B) detection.
Figure 3Graphical representation of the emerging biosensor technologies along with their applications.
Figure 4(A) Stretchable patch sensor for epidermal collection and analysis of sweat. Patch consists of colorimetric assays and reference colors. Adapted with permission from Ref. [103]. Copyright 2021, American Chemical Society. (B) A multiplex immunosensor for detection of TNF-α, IL-6, IL-8, TGF-β1, S. aureus, pH, and temperature for chronic wound monitoring. The device is integrated into a wireless, flexible, printed circuit board (PCB) and can be wearable. Adapted with permission from Ref. [36]. Copyright 2021, American Association for the Advancement of Science. (C) A closed bipolar electrode (CBE)-based two-cell electrochromic device for sensing multiple metabolites, using the simultaneous colorimetric detection of lactate, glucose, and uric acid as a model system. Adapted with permission from Ref. [60]. Copyright 2017, American Chemical Society.
Figure 5(A) Portable smartphone-based quantum barcode serological assay device for real-time SARS-CoV-2 diagnosis at different sampling dates and infectious severity. The device is based on a databasing app to provide instantaneous results. Adapted with permission from Ref. [44]. Copyright 2022, Elsevier. (B) The SARS-CoV-2 RapidPlex developed on target-specific, laser-engraved graphene immunoassays for PoC COVID-19 biomarkers. The electrochemical device is connected to a PCB and can send the signal to an app wirelessly. Adapted with permission from Ref. [37]. Copyright 2020, Elsevier. (C) A PoC microfluidic platform consisting of a homemade fluorescence detection analyzer, SARS-CoV-2 diagnostic microchips, and immunoassays for detecting IgG, IgM, and SARS-CoV-2 antigen. Adapted with permission from Ref. [114]. Copyright 2022, American Chemical Society.
Multiplexed PoC devices for health monitoring based on a smartphone readout.
| Target Analyte | Platform | Detection Method | Application | Evaluation in Real Samples | Information | Limit of Detection | Ref |
|---|---|---|---|---|---|---|---|
| Glucose, lactate, uric acid | Paper-based carbon electrode | Closed bipolar electrode-enabled electrochromic detection | Metabolite | - | Disposable and inexpensive, | Lactate: 180 μM | [ |
| Anti-HIV, anti-HA, anti-DEN | Microfluidic thread-based analytical device | Bioluminescence detection | Health monitoring | Human whole blood | Simple and rapid, | Anti-HIV: 4.0 nM | [ |
| SARS-CoV-2 nucleocapsid protein, specific immunoglobulins against SARS-CoV-2 S1 spike protein and CRP | Graphene-based telemedicine platform | Electrochemical detection | Infectious disease detection | Human blood and saliva | Rapid and effective, | - | [ |
| THC, alcohol | Ring-based sensor platform | Electrochemical detection | Illicit drug detection | Human saliva | Wearable | THC: 0.5 μM | [ |
| Inflammatory mediators | Microfluidic immunosensing platform | Electrochemical detection | Wound monitoring | Mouse wound model | Portable wireless analyzer, | - | [ |
| Sodium, potassium, calcium, pH, uric acid, and temperature | Functionalized micropatterned-electrode array smart bandage system | Electrochemical | Wound monitoring | Rat wound model | High sensitivity, stability, and reproducibility, | - | [ |
| Human coronavirus 229E, influenza A H1N1, influenza A H3N2 | Air sampler with enrichment channel-integrated handheld system | qRT-PCR | Virus detection | - | Rapid and real time, | - | [ |
| Alcohol, vitamins, glucose | Wearable tear bioelectronic platform | Microfluidic | Metabolite | Human tear | Wireless circuitry integrated into eyeglasses, | - | [ |
| Glucose, ethanol | Zinc oxide thin films integrated nanoporous electrode system | Impedance | Metabolite | Human sweat | Flexible | Ethanol: 10 mg/dL | [ |
| Alprazolam, citalopram, diazepam, fluvoxamine, imipramine, nortriptyline, sertraline, zolpidem | Condition-based sensor array | Colorimetric detection | Drug monitoring | Human urine | Rapid, visual, real time, | Flu: 0.4008 μg.mL−1 | [ |
| H1N1, H7N9, H5N1 | Label-free imaging array | Fluorescence detection | Health monitoring | Human serum | Good mismatch discrimination, low interference effect, | H1N1: 136 pM | [ |
| IL-6, thrombin | Lateral flow assays | Optical detection | Biomarker detection | - | Fast, simple, cost efficient, | Thrombin: 3.0 nM | [ |
| HIV, leukocytosis | Giant magnetoresistive nanosensor array | Magnetic detection | Monitoring disease | Human saliva | Additional circuitry, signal processing, user interface, mobile application | - | [ |
| Uric-acid, nitrite, glucose | Microfluidic paper-based analytical platform | Colorimetric detection | Metabolite | - | Biocompatible | Uric acid: 100 μM, Nitride: 156 μM, | [ |
| L-DOPA, tyrosine, creatinine | Periodate-modified paper platform | Colorimetric detection | Biomarker detection | Artificial urine, fetal bovine serum | Highly effective in simultaneous analysis | L-DOPA: 0.12 nM | [ |
| RASSF1A, SLC5A8 | Fe3O4@UiO-66 and AuNRs@C3N4 NS | Electrochemiluminescence detection | Cancer diagnostics | Cancer patient plasma sample | Monitoring | RASSF1A: 0.86 pM | [ |
| Zika, Dengue, Chikungunya viruses | Complementary metal oxide semiconductor sensor | Colorimetric detection | Virus detection | Blood, urine, and saliva | Small footprint and versatility of smartphones | Zika Virus: 22 PFU/mL Dengue: 4.9 PFU/mL | [ |
| Prostate-specific antigen (PSA), human chorionic gonadotropin (hCG) | Multicolor persistent luminescent nanophosphors | Luminescent detection | Health monitoring | - | High sensitivity and photostability, | PSA: 0.1 ng mL−1 | [ |
| Pipette-actuated capillary array comb | LAMP reaction | Pathogen detection | Urine | Process takes 85 min | [ |